Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages

Choi, 2006, Biosensing with conically shaped nanopores and nanotubes, Phys. Chem. Chem. Phys., 8, 4976, 10.1039/b607360c

Giri, 2005, Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles, Angew. Chem. Int. Ed., 44, 5038, 10.1002/anie.200501819

Ferrari, 2005, Cancer nanotechnology: opportunities and challenges, Nat. Rev. Cancer, 5, 161, 10.1038/nrc1566

Chen, 2005, Gold nanocages; engineering their structure for biomedical applications, Adv. Mater., 17, 2255, 10.1002/adma.200500833

Hirsch, 2003, Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance, Proc. Natl. Acad. Sci., 100, 13549, 10.1073/pnas.2232479100

Ryan, 2008, Nanodisk: hydrophobic drug delivery vehicles, Expert Opin. Drug Deliv., 5, 343, 10.1517/17425247.5.3.343

Torchilin, 2009, Multifunctional and stimuli-sensitive pharmaceutical nanocarriers, Eur. J. Pharm. Biopharm., 71, 431, 10.1016/j.ejpb.2008.09.026

Chithrani, 2006, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells, Nanoletters, 6, 662, 10.1021/nl052396o

Chen, 2009, Assessment of the in vivo toxicity of gold nanoparticles, Nanoscale Res. Lett., 4, 858, 10.1007/s11671-009-9334-6

Nan, 2008, Cellular uptake and cytotoxicity of silica nanotubes, Nano Lett., 8, 2150, 10.1021/nl0802741

Parkin, 2005, Global cancer statistics, 2002, CA Cancer J. Clin., 55, 74, 10.3322/canjclin.55.2.74

Ozols, 2005, Treatment goals in ovarian cancer, Int. J. Gynecol. Cancer, 15, 3, 10.1111/j.1525-1438.2005.15351.x

Paciotti, 2004, Colloidal gold; a novel nanoparticle vector for tumor directed drug delivery, Drug Deliv., 11, 169, 10.1080/10717540490433895

Thomas, 2003, Conjugation to gold nanoparticles enhances polyethylenimine’s transfer of plasmid DNA into mammalian cells, Proc. Natl. Acad. Sci., 100, 9138, 10.1073/pnas.1233634100

Salem, 2003, Multifunctional nanorods for gene delivery, Nat. Mater., 2, 668, 10.1038/nmat974

Jain, 2007, Au nanoparticles target cancer, Nanotoday, 2, 18, 10.1016/S1748-0132(07)70016-6

Huang, 2007, Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy, Nanomedicine, 5, 681, 10.2217/17435889.2.5.681

Semmler-Behnke, 2008, Biodistribution of 1. 4-and 18-nm gold particles in rats, Small, 4, 108, 10.1002/smll.200800922

Lipka, 2010, Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection, Biomaterials, 31, 6574, 10.1016/j.biomaterials.2010.05.009

Vlerken, 2007, Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery, Pharm. Res., 24, 1405, 10.1007/s11095-007-9284-6

Arnida, A. Malugin, H. Ghandehari, Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres, J. Appl. Toxicol. 30 (2010) 212–217.

Inan, 2006, Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta’s in epithelial ovarian tumors, Histol. Histopathol., 21, 1055

Akiyama, 2009, The effect of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice, J. Control. Release, 139, 81, 10.1016/j.jconrel.2009.06.006

Yokoyama, 1991, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood, Cancer Res., 51, 3229

Niidome, 2006, PEG-modified gold nanorods with a stealth character for in vivo application, J. Control. Release, 114, 343, 10.1016/j.jconrel.2006.06.017

Moghimi, 1991, Non-phagocytic uptake of intravenously injected microsphere in rat spleen; influence of particle size and hydrophilic coating, Biochem. Biophys. Res. Commun., 177, 861, 10.1016/0006-291X(91)91869-E

Harris, 1992

Kreibig, 1985, Optical absorption of small metallic particles, Surf. Sci., 156, 678, 10.1016/0039-6028(85)90239-0

Sarkar, 1997, General vector basis function solution of Maxwell’s equations, Phys. Rev. E, 56, 1102, 10.1103/PhysRevE.56.1102

Novak, 2000, Assembly of phenylacetylene-bridged silver and gold nanoparticle arrays, J. Am. Chem. Soc., 122, 3979, 10.1021/ja000477a

Sun, 2002, Increased sensitivity of surface plasmon resonance of gold nanoshells compared to that of gold solid colloids in response to environmental changes, Anal. Chem., 74, 5297, 10.1021/ac0258352

Haynes, 2001, Nanosphere lithography: a versatile nanofabrication tool for studies of size-dependent nanoparticle optics, J. Phys. Chem. B, 105, 5599, 10.1021/jp010657m

Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016/S0168-3659(99)00248-5

Gregoriadis, 1998, Observations on entrapped solute retention, vesicle clearance and tissue distribution in vivo, 3

Illum, 1984, The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (poloxamer 338), FEBS Lett., 167, 79, 10.1016/0014-5793(84)80836-4

Moghimi, 1994, Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection, Crit. Rev. Ther. Drug Carr. Syst., 11, 1089

Levchenko, 2002, Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating, Int. J. Pharm., 240, 95, 10.1016/S0378-5173(02)00129-1

Gordon, 1995, The macrophage, Bioessay, 17, 977, 10.1002/bies.950171111

Poznansky, 1985, Biological approaches to the controlled delivery of drugs: a critical review, Pharmacol. Rev., 36 277, 277

Lars, 2003, Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages, Pharm. Res., 20, 221, 10.1023/A:1022271020390

Champion, 2009, Shape induced inhibition of phagocytosis of polymer particles, Pharm. Res., 26, 244, 10.1007/s11095-008-9626-z

Champion, 2006, Role of target geometry in phagocytosis, Proc. Natl. Acad. Sci., 103, 4930, 10.1073/pnas.0600997103

Huang, 2010, The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function, Biomaterials, 31, 438, 10.1016/j.biomaterials.2009.09.060

Chithrani, 2006, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells, Nanoletters, 6, 662, 10.1021/nl052396o

Alemdaroglu, 2008, Cellular uptake of DNA block copolymer micelles with different shapes, Macromol. Rapid Commun., 29, @@nbsp;326, 10.1002/marc.200700779

Owend, 2006, Opsonization biodistribution and pharmacokinetics of polymeric nanoparticles, Int. J. Pharm., 307, 93, 10.1016/j.ijpharm.2005.10.010

Bradfield, 1984, 25

Brewer, 2005, Probing BSA binding to citrate-coated gold nanoparticles and surfaces, Langmuir, 21, 9303, 10.1021/la050588t

Sandros, 2005, General high affinity approach for the synthesis of fluorophore appended protein nanoparticle assemblies, Chem. Commun., 22, 2832, 10.1039/b501315a

Takakura, 1994, Pharmacokinetics of succinylated proteins and dextran sulfate in mice: implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors, Int. J. Pharm., 105, 19, 10.1016/0378-5173(94)90231-3

Jansen, 1991, Formaldehyde treated albumin contains monomeric and polymeric forms that are differently cleared by endothelial and Kupffer cells of the liver: evidence for scavenger receptor heterogeneity, Biochem. Biophys. Res. Commun., 180, 23, 10.1016/S0006-291X(05)81249-5

Rigotti, 1995, The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids, J. Biol. Chem., 270, 16221, 10.1074/jbc.270.27.16221

Geng, 2007, Shape effects of filaments versus spherical particles in flow and drug delivery, Nat. Nanotechnol., 2, 249, 10.1038/nnano.2007.70